Literature DB >> 645948

Prediction of antidepressant responses to lithium.

E F Donnelly, F K Goodwin, I N Waldman, D L Murphy.   

Abstract

The authors studied 53 patients hospitalized for depression to evaluate possible associations between pretreatment responses to the Minnesota Multiphasic Personality Inventory and behaviorally rated responses to lithium. Patients were randomly assigned to two groups (A and B) in which responders and nonresponders were balanced for sex. For the 18 women in group A, a lithium response scale discriminated responders with 89% accuracy. For the 9 males, a separate scale discriminated responders with 100% accuracy. In a cross-validation, the two scales discriminated responders and nonresponders with 100% accuracy in group B. The empirical methodology of this study suggests an alternative to the theoretical-rational approach of predicting response to antidepressant drugs based on pretreatment depressive symptoms.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 645948     DOI: 10.1176/ajp.135.5.552

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  7 in total

Review 1.  Bipolar depression: management options.

Authors:  Gin S Malhi; Philip B Mitchell; Shahzad Salim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

3.  Obsessionalism and response to lithium.

Authors:  E F Donnelly; D L Murphy; I N Waldman
Journal:  Br Med J       Date:  1979-06-16

4.  Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.

Authors:  Lakshmi N Yatham; Sidney H Kennedy; Sagar V Parikh; Ayal Schaffer; David J Bond; Benicio N Frey; Verinder Sharma; Benjamin I Goldstein; Soham Rej; Serge Beaulieu; Martin Alda; Glenda MacQueen; Roumen V Milev; Arun Ravindran; Claire O'Donovan; Diane McIntosh; Raymond W Lam; Gustavo Vazquez; Flavio Kapczinski; Roger S McIntyre; Jan Kozicky; Shigenobu Kanba; Beny Lafer; Trisha Suppes; Joseph R Calabrese; Eduard Vieta; Gin Malhi; Robert M Post; Michael Berk
Journal:  Bipolar Disord       Date:  2018-03-14       Impact factor: 6.744

Review 5.  Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Authors:  Jorge M Tamayo; Carlos A Zarate; Eduard Vieta; Gustavo Vázquez; Mauricio Tohen
Journal:  Int J Neuropsychopharmacol       Date:  2010-02-04       Impact factor: 5.176

Review 6.  Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses.

Authors:  Konstantinos N Fountoulakis; Mauricio Tohen; Carlos A Zarate
Journal:  Eur Neuropsychopharmacol       Date:  2022-01       Impact factor: 4.600

Review 7.  Lithium in bipolar disorder: can drug concentrations predict therapeutic effect?

Authors:  Beth Sproule
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.